Transaction · 0001193125-26-359255

Mahoney David L

MAHONEY DAVID L, DIR, reported an open-market or private sale at CORCEPT THERAPEUTICS INC involving 91167.000000 shares for an estimated $10779367.28. Reported holdings after the transaction were 1140994.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SDIR
CORTCORCEPT THERAPEUTICS INC
Estimated value-$10.7MShares × reported price
Shares traded91.1k$118.24 per share
Holdings after1.14MIndirect · Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust
% of reported position traded7.4%This security and ownership context
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 1,232,161 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

CORT price since this filing

Daily closing prices, with the filing date and available return windows
CORT · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago -25.2%1w ago -7.6%1d ago -3.2%
Returns since7d -3.4%30d -8.9%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001193125-26-359255
Common Stock
Transaction date
Aug 18, 2026
Filed Aug 20, 2026, 08:30 PM · 2d delay
Shares
91,167 sh
$118.24 per share
Estimated value
-$10.7M
Computed from shares × price
Holdings after
1,140,994 sh
Indirect · Held by David L. Mahoney and Winnifred C. Ellis 1998 Family Trust

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Cluster Selling Large Sale Repeat Seller 10b5-1 Detected
Filing-only score

-6 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • timely_filing+4 points

    reporting_delay_days = 2

    Filing reported within two business days of the transaction.
  • tenb5_1_detected-10 points

    is_10b5_1 = true

    Stored filing content includes detected 10b5-1 language.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on May 11, 2026 in effect at the time of this transaction.

  2. F2

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.595 to $117.59. Information on the exact number of shares sold at each sale pric…

  3. F3

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.60 to $118.595. Information on the exact number of shares sold at each sale pric…

  4. F4

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.60 to $119.345. Information on the exact number of shares sold at each sale pric…

  5. F5

    Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.605 to $119.6775. Information on the exact number of shares sold at each sale pr…

Original filing · 0001193125-26-359255
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

CORT